RK

Ramesh Kumar Panchayathu Madathil Raveendra Panicker

Director Managing Director DIN 02635010
DIN 02635010 First appointment Jul 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jul 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramesh Kumar Panchayathu Madathil Raveendra Panicker

Data last updated:

Ramesh Kumar Panchayathu Madathil Raveendra Panicker was a Managing Director at Lycus Pharma Private Limited (2009–2012). The company operates in Pharma.

DIN 02635010
Primary Designation Managing Director
Industry Pharma
First Appointment 06 Jul 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lycus Pharma Private Limited U52311KL2009PTC024412
Managing Director06 Jul 20092009₹3.00 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lycus Pharma Private Limited
Premium access

Shareholding and investment profile for Ramesh Kumar Panchayathu Madathil Raveendra Panicker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Kumar Panchayathu Madathil Raveendra Panicker

Ramesh Kumar Panchayathu Madathil Raveendra Panicker was first appointed on 06 Jul 2009 as Managing Director at Lycus Pharma Private Limited.

Ramesh Kumar Panchayathu Madathil Raveendra Panicker held 1 earlier board appointment: Lycus Pharma Private Limited (Managing Director, 06 Jul 2009 to 30 Mar 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available